Epithelial-mesenchymal transformation of embryonic cardiac endothelial cells is inhibited by a modified antisense oligodeoxynucleotide to transforming growth factor …

JD Potts, JM Dagle, JA Walder… - Proceedings of the …, 1991 - National Acad Sciences
JD Potts, JM Dagle, JA Walder, DL Weeks, RB Runyan
Proceedings of the National Academy of Sciences, 1991National Acad Sciences
During early cardiac development, the progenitor cells of the heart valves and membranous
septa undergo an epithelial-mesenchymal transformation. Previous studies have shown that
this transformation depends on the activity of a transforming growth factor beta (TGF beta)
molecule produced by the heart. In the present study, we have used modified antisense
oligodeoxynucleotides generated to nonconserved regions of TGF beta 1,-2,-3, and-4 to
examine the possible roles of these members in this transformation. A phosphoramidate …
During early cardiac development, the progenitor cells of the heart valves and membranous septa undergo an epithelial-mesenchymal transformation. Previous studies have shown that this transformation depends on the activity of a transforming growth factor beta (TGF beta) molecule produced by the heart. In the present study, we have used modified antisense oligodeoxynucleotides generated to nonconserved regions of TGF beta 1, -2, -3, and -4 to examine the possible roles of these members in this transformation. A phosphoramidate-modified oligonucleotide complementary to TGF beta 3 mRNA was capable of inhibiting normal epithelial-mesenchymal transformation by 80%. Unmodified oligonucleotides to TGF beta 3, modified oligonucleotides to TGF beta 1, -2, and -4, and two modified control oligonucleotides were unable to inhibit the transformation. These data demonstrate that a specific member of the TGF beta family, TGF beta 3, is essential for the epithelial-mesenchymal cell transformation.
National Acad Sciences